OTCMKTS:RKAGY

RHÖN-KLINIKUM Aktiengesellschaft (RKAGY) Stock Price, News & Analysis

$6.05
0.00 (0.00%)
(As of 04/24/2024 ET)
Today's Range
$6.05
$6.05
50-Day Range
$5.41
$6.51
52-Week Range
$5.41
$6.51
Volume
N/A
Average Volume
150 shs
Market Capitalization
N/A
P/E Ratio
1.34
Dividend Yield
1.36%
Price Target
N/A
RKAGY stock logo

About RHÖN-KLINIKUM Aktiengesellschaft Stock (OTCMKTS:RKAGY)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

RKAGY Stock Price History

RKAGY Stock News Headlines

See More Headlines
Receive RKAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
OTCMKTS:RKAGY
CIK
N/A
Fax
N/A
Employees
18,158
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Dr. Tobias Kaltenbach (Age 64)
    Chairman of Management Board
    Comp: $592.5k
  • Dr. Stefan Stranz (Age 47)
    CFO & Member of Management Board
    Comp: $723.56k
  • Dr. Gunther Karl Weiß M.Sc. (Age 56)
    COO & Member of Management Board
    Comp: $766.89k
  • Julian Schmitt
    Head of Investor Relations & Treasury
  • Mr. Eugen Münch
    Chief Representative

RKAGY Stock Analysis - Frequently Asked Questions

How have RKAGY shares performed in 2024?

RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at $5.4148 at the start of the year. Since then, RKAGY stock has increased by 11.7% and is now trading at $6.05.
View the best growth stocks for 2024 here
.

Are investors shorting RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 500 shares, an increase of 25.0% from the March 15th total of 400 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 5.0 days.
View RHÖN-KLINIKUM Aktiengesellschaft's Short Interest
.

How often does RHÖN-KLINIKUM Aktiengesellschaft pay dividends? What is the dividend yield for RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft declared a dividend on Friday, June 2nd. Shareholders of record on Friday, June 9th will be given a dividend of $0.0522 per share on Wednesday, June 28th. This represents a yield of 0.77%. The ex-dividend date is Thursday, June 8th.
Read our dividend analysis for RKAGY
.

Is RHÖN-KLINIKUM Aktiengesellschaft a good dividend stock?

RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY) pays an annual dividend of $0.08 per share and currently has a dividend yield of 5.34%. RKAGY has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 1.83%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for RKAGY.

How do I buy shares of RHÖN-KLINIKUM Aktiengesellschaft?

Shares of RKAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RKAGY) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners